Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes.
about
Genetic variants including markers from the exome chip and metabolite traits of type 2 diabetes.Lipidomics: Prospects from a technological perspective.Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes.A Decade of Genetic and Metabolomic Contributions to Type 2 Diabetes Risk Prediction.Metabolomics signatures associated with an oral glucose challenge in pregnant women.Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance.
P2860
Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Non-targeted metabolomics comb ...... with incident type 2 diabetes.
@en
Non-targeted metabolomics comb ...... with incident type 2 diabetes.
@nl
type
label
Non-targeted metabolomics comb ...... with incident type 2 diabetes.
@en
Non-targeted metabolomics comb ...... with incident type 2 diabetes.
@nl
prefLabel
Non-targeted metabolomics comb ...... with incident type 2 diabetes.
@en
Non-targeted metabolomics comb ...... with incident type 2 diabetes.
@nl
P2093
P2860
P50
P1433
P1476
Non-targeted metabolomics comb ...... with incident type 2 diabetes.
@en
P2093
Christian Berne
Christoph Nowak
Corey D Broeckling
Nancy L Pedersen
Stefan Brandmaier
Vilmantas Giedraitis
P2860
P2888
P304
P356
10.1007/S00125-016-4041-1
P50
P577
2016-07-12T00:00:00Z